Incorrect Table. In the Original Contribution entitled "Menopausal Hormone Replacement
Therapy and Risk of Ovarian Cancer" published in the July 17, 2002, issue
of THE JOURNAL (2002;288:334-341), there were errors in Table 1. On page 336,
in Table 1, the last 4 lines of the table are replaced
by the 4 lines shown in this corrected Table 1.
Table. Prevalence of HRT Use by Selected Factors*
Factor
% of Person-Years†
Total Person-Years‡
None
ERT Only
EPRT Following ERT
EPRT Only
ERT Only, Unknown Use of Progestins
Unknown HRT
BCDDP participant type
Breast surgery; no malignant disease
45
32
6
7
5
5
246 385
No surgery performed or recommended
46
30
6
7
6
5
248 813
Recommended for surgery
49
28
6
7
6
5
94 015
*HRT indicates hormone replacement therapy; ERT, estrogen replacement
therapy; EPRT, estrogen-progestin replacement therapy; and BCDDP, Breast Cancer
Detection Demonstration Project.
†Percentages may not sum to 100 because of rounding.
‡Excludes 3884 person-years among women with progestins-only
use and 402 person-years among women with "progestin, estrogen unknown" use.